The FDA alerted providers to a shortage of pediatric breathing tubes manufactured by Smiths Medical. The Bivona tracheostomy tubes are used in healthcare facilities and at home to help adult and pediatric patients breathe. While approved for use in both adult and pediatric patients, the temporary shortage is likely to affect pediatric patients because there is a limited supply of other alternatives, according to the FDA notice.
The FDA is working with Smiths Medical to “quickly resolve their sterilization challenges and bring these critical devices to the patients who need them as quickly as possible,” according to the notice. They expect the critical devices to be available again the week of April 22.
Another supplier, Guerbet USA, alerted customers in March that its “consumables for Optistar, Optivantage and Illumena power injectors may experience limited availability” until the sterilization issues are resolved.
Additionally, Cardinal Health alerted customers of a temporary supply shortage of its Kendall intrauterine pressure catheter related to the sterilization facility closure, according to a customer letter obtained by Becker’s.
The shortages are expected to be temporary.
More articles on supply chain:
FDA braces for medical device shortages: 9 things to know
Reports of breast implant ‘illness’ spur FDA safety review
5 supply chain technologies to watch
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.